A A Khan1, I Birks-Agnew, P Bullock, D Rushton. Show Affiliations » 1. Kings College Hospital, London, UK. akbaralikhan77@hotmail.com
Abstract
Entities: Chemical Disease Species
Mesh： See more » AdultBaclofen/administration & dosageBaclofen/adverse effectsEquipment FailureFemaleForeign-Body MigrationHumansInfusion Pumps, Implantable/adverse effectsInjections, SpinalMaleMiddle AgedMultiple Sclerosis/drug therapyMultiple Sclerosis/physiopathologyMuscle Relaxants, Central/administration & dosageMuscle Relaxants, Central/adverse effectsMuscle Spasticity/drug therapyMuscle Spasticity/physiopathologyRecovery of Function/drug effectsRetrospective StudiesSeverity of Illness IndexTreatment Outcome
Substances： See more » Muscle Relaxants, CentralBaclofen
Year: 2010 PMID： 20871140 DOI： 10.3233/NRE-2010-0587
Source DB: PubMed Journal: NeuroRehabilitation ISSN： 1053-8135 Impact factor: 2.138